Pacs Group (PACS) closed at $45.85 on October 19, 2026, down 2.3% from the previous close, on volume of 576,660 shares (30-day average 759,370).
Data as of October 19, 2026.
19-Oct-2026
Omega to Transition Operations of 32 Facilities in Florida to PACS Group
Business Wire (Mon, 5-Oct 2:00 AM ET)
Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
Business Wire (Wed, 30-Sep 6:08 PM ET)
Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Fri, 25-Sep 11:16 PM ET)
Market Chameleon (Tue, 22-Sep 5:01 AM ET)
PACS Group Announces Chief Legal Officer Transition
Business Wire (Mon, 21-Sep 4:15 PM ET)
Business Wire (Mon, 14-Sep 9:15 AM ET)
Business Wire (Tue, 1-Sep 4:15 PM ET)
PACS Group, Inc. Reports Second Quarter 2026 Results
Business Wire (Tue, 4-Aug 4:30 PM ET)
PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 28-Jul 4:30 PM ET)
Business Wire (Thu, 23-Jul 7:00 AM ET)
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Pacs Group trades on the NYSE stock market under the symbol PACS.
As of October 19, 2026, PACS stock price declined to $45.85 with 576,660 million shares trading.
PACS has a beta of -0.64, meaning it tends to be less sensitive to market movements. PACS has a correlation of 0.01 to the broad based SPY ETF.
PACS has a market cap of $7.26 billion. This is considered a Mid Cap stock.
Last quarter Pacs Group reported $1 billion in Revenue and $.47 earnings per share. This beat revenue expectation by $6 million and missed earnings estimates by -$.10.
The top ETF exchange traded funds that PACS belongs to (by Net Assets): VTI, AVUV, IWM, VB, DFAS.
PACS has outperformed the market in the last year with a price return of +274.0% while the SPY ETF gained +16.5%. However, in the short term, PACS had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.6% vs +3.4% return in SPY. But in the last 2 weeks, PACS shares have fared better than the market returning +7.4% compared to SPY -1.1%.
PACS support price is $45.75 and resistance is $48.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACS shares will trade within this expected range on the day.